October 2024 | Deals & Transactions
Luye Pharma Group Ltd. US$100 million 5.85% Convertible Bonds due 2025
October 2024 | Deals & Transactions
UP Fintech Holding Limited US$103.65 Million Follow-On Nasdaq Offering
October 2024 | Deals & Transactions
SAG Holdings Limited US$7 million Nasdaq IPO
October 2024 | Deals & Transactions
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) US$525 Million Acquisition of Ironshore Therapeutics Inc.
October 2024 | Press Releases
Conyers Continues Growth in Asia with Lawyer Promotions
October 2024 | Alerts, News
The Bermuda Economic Substance Regime – Are You in Compliance?
October 2024 | Deals & Transactions
SKK Holdings Limited US$10 Million Nasdaq IPO
October 2024 | Deals & Transactions
Golar LNG US$300 Million Unsecured Bonds Issuance
October 2024 | Press Releases
Conyers announces Norman Hau as Hong Kong Head of Disputes and Restructuring
Disclaimers: These publications are not intended to be a substitute for legal advice or a legal opinion. They deal in broad terms, are intended as a brief overview, and give general information.
Effective 3 December 2020, all legislation in the Cayman Islands is described by the term “Act” rather than “Law”. Any references to “Law” (and accompanying acronyms) in Conyers written materials pre-dating October 2020 should be read as “Act”.
Effective 3 December 2020, all legislation in the Cayman Islands is described by the term “Act” rather than “Law”. Any references to “Law” (and accompanying acronyms) in Conyers written materials pre-dating October 2020 should be read as “Act”.